| Zhanna Spektor, MD | |
|
750 E. Adams Street, Syracuse, NY 13210 | |
| (315) 464-6751 | |
| (315) 464-6749 |
| Full Name | Zhanna Spektor |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 39 Years |
| Location | 750 E. Adams Street, Syracuse, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164642971 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Hospital S U N Y Health Science Center | Syracuse, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Pathologists Laboratories, Llp | 8325038276 | 23 |
News Archive
Many drug companies desperately do not want revealed to the public that over-the-counter hemorrhoid treatments may worsen problems and cause skin damage.
Seasonal flu vaccines may protect individuals not only against the strains of flu they contain but also against many additional types, according to a study published this week in mBio, the online open-access journal of the American Society for Microbiology.
During the first three months after stroke, the risk for depression was eight times higher than in a reference population of people without stroke, according to an article published online by JAMA Psychiatry.
Bayer HealthCare and Onyx Pharmaceuticals today announced that Bayer HealthCare has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the oral multi-kinase inhibitor regorafenib for the treatment of metastatic and/or unresectable gastrointestinal stromal tumors (GIST) in patients whose disease has progressed despite prior treatment.
› Verified 4 days ago
| Entity Name | University Pathologists Laboratories, Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033150917 PECOS PAC ID: 8325038276 Enrollment ID: O20040513001074 |
News Archive
Many drug companies desperately do not want revealed to the public that over-the-counter hemorrhoid treatments may worsen problems and cause skin damage.
Seasonal flu vaccines may protect individuals not only against the strains of flu they contain but also against many additional types, according to a study published this week in mBio, the online open-access journal of the American Society for Microbiology.
During the first three months after stroke, the risk for depression was eight times higher than in a reference population of people without stroke, according to an article published online by JAMA Psychiatry.
Bayer HealthCare and Onyx Pharmaceuticals today announced that Bayer HealthCare has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the oral multi-kinase inhibitor regorafenib for the treatment of metastatic and/or unresectable gastrointestinal stromal tumors (GIST) in patients whose disease has progressed despite prior treatment.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Zhanna Spektor, MD 224 Harrison Street Ste 600, Syracuse, NY 13202 Ph: (315) 464-6751 | Zhanna Spektor, MD 750 E. Adams Street, Syracuse, NY 13210 Ph: (315) 464-6751 |
News Archive
Many drug companies desperately do not want revealed to the public that over-the-counter hemorrhoid treatments may worsen problems and cause skin damage.
Seasonal flu vaccines may protect individuals not only against the strains of flu they contain but also against many additional types, according to a study published this week in mBio, the online open-access journal of the American Society for Microbiology.
During the first three months after stroke, the risk for depression was eight times higher than in a reference population of people without stroke, according to an article published online by JAMA Psychiatry.
Bayer HealthCare and Onyx Pharmaceuticals today announced that Bayer HealthCare has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the oral multi-kinase inhibitor regorafenib for the treatment of metastatic and/or unresectable gastrointestinal stromal tumors (GIST) in patients whose disease has progressed despite prior treatment.
› Verified 4 days ago
Dr. Diana A Dimitrov, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 1226 E Water St, Syracuse, NY 13210 Phone: 315-478-4185 | |
Dr. Michael A Jozefczyk, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 600 E Genesee St, Suite 305, Syracuse, NY 13202 Phone: 315-234-3300 | |
Dr. Matthew Brian Elkins, M.D., PH.D Pathology Medicare: Accepting Medicare Assignments Practice Location: 750 E. Adams Street, Syracuse, NY 13210 Phone: 315-464-6751 Fax: 315-464-6749 | |
Dr. Christian N Ezidiegwu, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 100 Ostrom Ave, Syracuse, NY 13210 Phone: 315-447-7041 | |
Dr. Robert John Corona Jr., DO, CPE Pathology Medicare: Medicare Enrolled Practice Location: 750 E. Adams Street, Syracuse, NY 13210 Phone: 315-464-6751 Fax: 315-464-6749 | |
Lazaro Rosales, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-6751 Fax: 315-464-6749 | |
Diandra Perez, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-7117 |